INZY Stock Outstanding Shares
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
ShortableYes
OptionableYes
Short Percent Of Outstanding Shares6
Short Percent Of Float6.49
Shares Outstanding64.24M
Shares Float36.52M
Shares Short3.85M
Short Ratio5.41
6.49%
Short % of Float6%
Short % of Shares OutstandingMarket Insider INZY
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
Major Holders Summary
0.62% Percentage of Shares held by All Insiders
99.31% Percentage of Shares held by All Institutions
99.93% Percentage of Float held by Institutions
126
Number of Institutions Holding SharesInstitutional Ownership
About 99.31% of INZY shares are held by financial institutions. SUSQUEHANNA INTERNATIONAL GROUP, LLP is the top corporate investor, holding 30.15K shares valued at $230.98K. A 0.06% stake in Inozyme Pharma, Inc. is owned by the company. NISA INVESTMENT ADVISORS, LLC owns 24 shares valued at $184.00, which translates its holding of 0% of the stake in the company.
INZY Insiders
Among the INZY insiders holding of 0.62% of the stake in company, ENRIGHT PATRICK G, , holds the largest shares of 4.17M. LONGITUDE CAPITAL PARTNERS III, LLC, 10 percent owner, is the second largest INZY insider with ownership of 4.17M shares. PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P., LTD, , stands third with possession of 2.66M shares of that stake.
Buying/Selling by Insiders
Frequently Asked Questions
How many institutions own INZY stock?
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own INZY shares is 126, representing 99.31% of the company's common stock.
Who are the major shareholders selling Inozyme Pharma, Inc. stock?
SUSQUEHANNA INTERNATIONAL GROUP, LLP, in the last quarter, reduced its stake in INZY by -30.93% restricting it's holding to 30.15 thousand shares of worth nearly $230.98K. ADAGE CAPITAL PARTNERS GP, L.L.C. also lessened -3.77% of the INZY shares from its portfolio, reducing its holding to 5.33 million shares of worth $40.82M. FMR LLC also shunned INZY shares holding by -13.42% last quarter which brought its holding to 1.97 million shares worth $15.07M.
Investors who are buying INZY stock?
As per its latest 13F filing, NISA INVESTMENT ADVISORS, LLC increased its stake in INZY by 100% in the last quarter. The institutional holder raised its holding to 24 shares having worth more than $184.00. GOLDMAN SACHS GROUP INC also added 12.81% more shares of INZY to its portfolio, raising its holding to 409.92 thousand shares of worth $3.14M. AFFINITY ASSET ADVISORS, LLC also increased its INZY shares holding by 40.13% which brought its holding to 2.64 million shares worth $20.24M.
INZY's major insiders: who are they?
The insider with the most stakes in INZY is ENRIGHT PATRICK G , at the company. Additionally, INZY stock is highly held by 10 percent owner Longitude Capital Partners III, LLC and Pivotal bioVenture Partners Fund I U.G.P., Ltd among others.
Did an insider recently sell INZY stock?
Company executives, directors, and other insiders own 0.62% percent of Inozyme Pharma, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which INZY insiders have sold stock, totaling 0 shares. Insiders that have sold shares include TRECO DOUGLAS A, BOLTE AXEL, and NOVO HOLDINGS A/S.
Which insider recently purchased INZY stock?
There have been 0 transaction(s) during the past 6-months in which Inozyme Pharma, Inc. insiders have bought stock, totalling 0 shares
How much of INZY does insiders own?
Around 0 Inozyme Pharma, Inc. shares are held by insiders, which represents about 0.62% of INZY stock.
Who is the insider with the largest stake?
INZY , ENRIGHT PATRICK G holds the largest portfolio of the company's shares. INZY shares owned by ENRIGHT total nearly 4.17 million.
Which institution holds the most shares in INZY?
SUSQUEHANNA INTERNATIONAL GROUP, LLP is the largest institutional owner in INZY which holds 30.15 thousand shares worth $230.98K or 0.06% of the total INZY shares outstanding followed by NISA INVESTMENT ADVISORS, LLC with ownership of 24 shares representing 0% of the INZY ownership. PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC is the third largest stakeholder with 4.49 million shares or 8.67% of the ownership worth more than $34.43M.
Is Inozyme Pharma, Inc. stock optionable?
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the INZY is concerned, it is a stock which is optionable.
Is there a short position on INZY's shares?
Number of INZY shares short is 3.85M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
About how many outstanding INZY shares are there?
As of today, 64.24M shares of INZY are outstanding.
Is there many float in INZY stock?
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, INZY has 36.52M shares in float.
INZY short ratio: what is it?
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for INZY is 5.41.